Asymmetric retinopathy of prematurity in presumed fungal endophthalmitis.
Endophthalmitis
Pediatric retina
Retina
Retinopathy of prematurity
Journal
American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
29
11
2019
revised:
11
04
2020
accepted:
18
04
2020
entrez:
9
5
2020
pubmed:
10
5
2020
medline:
10
5
2020
Statut:
epublish
Résumé
To report a case of asymmetric retinopathy of prematurity (ROP) in a neonate with endophthalmitis. A 25-week old female was born by caesarean section due to preeclampsia. The patient required supplemental oxygen after birth. The neonatal period was complicated by sepsis secondary to necrotizing enterocolitis with intestinal perforation. The patient subsequently developed endophthalmitis in the right eye. A fungal ball was seen overlying the termination of a persistent hyaloid artery. The patient also had ROP, identified at 31 weeks postconceptional age, which progressed asymmetrically and demonstrated greater severity in the eye affected by endophthalmitis. The endophthalmitis resolved with intravitreal antifungal treatment and systemic therapy. The right eye was also treated with intravitreal bevacizumab, demonstrating regression of ROP severity on follow up. The present case describes the first reported case of asymmetric ROP associated with endophthalmitis. The more severe ROP occurred in the eye with endophthalmitis suggesting that, outside of systemic factors, the local ocular inflammatory environment is important in determining the progression of ROP. Additionally, the fungal ball present in the eye affected by endophthalmitis was seen at the termination of the hyaloid artery, suggesting the hyaloid artery as the route of entry of the fungus into the vitreous.
Identifiants
pubmed: 32382688
doi: 10.1016/j.ajoc.2020.100722
pii: S2451-9936(20)30076-1
pii: 100722
pmc: PMC7200213
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100722Informations de copyright
© 2020 Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Dr Audina M. Berrocal reports the following disclosures: Administrative board member for Allergan PLC and Bayer; Consultant for Alcon, Dorc (Dutch Ophthalmic Research Center International BV), Visunex, and Phoenix. The following authors have nothing to disclose: HA, NAP, KCF, TAL, NAY, BF, CN.
Références
Angiogenesis. 2007;10(2):133-40
pubmed: 17332988
Retina. 2009 Mar;29(3):362-70
pubmed: 18997637
Br J Ophthalmol. 1954 Jul;38(7):397-432
pubmed: 13172417
PLoS One. 2014 Oct 15;9(10):e109460
pubmed: 25330287
Arch Ophthalmol. 2011 Dec;129(12):1555-63
pubmed: 22159674
Semin Fetal Neonatal Med. 2012 Feb;17(1):26-9
pubmed: 21903492
J Ocul Pharmacol Ther. 2008 Apr;24(2):245-8
pubmed: 18321199
J Pediatr Ophthalmol Strabismus. 2019 Oct 17;56:e60-e64
pubmed: 31622479
Br J Ophthalmol. 2008 Jul;92(7):871-8
pubmed: 18577634
Pediatr Res. 2010 Apr;67(4):394-400
pubmed: 20032809
Am J Physiol. 1954 Oct;179(1):115-8
pubmed: 13207397
Pediatrics. 2010 Apr;125(4):e736-40
pubmed: 20231184
Arch Ophthalmol. 2001 Aug;119(8):1110-8
pubmed: 11483076
Invest Ophthalmol Vis Sci. 2007 May;48(5):2238-41
pubmed: 17460285
Br J Ophthalmol. 1963 Jan;47:39-44
pubmed: 14186858
Toxicology. 2009 Apr 28;258(2-3):84-93
pubmed: 19428927
N Engl J Med. 2012 Dec 27;367(26):2515-26
pubmed: 23268666
Am J Perinatol. 2005 Feb;22(2):115-20
pubmed: 15731992
Pediatrics. 2005 Apr;115(4):990-6
pubmed: 15805375
Arch Ophthalmol. 2004 Nov;122(11):1687-92
pubmed: 15534131
N Engl J Med. 1992 Apr 16;326(16):1050-4
pubmed: 1549150
Infect Immun. 1996 Jul;64(7):2609-17
pubmed: 8698486